Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin
E Dahmane, PR Hutson… - Clinical Pharmacology in …, 2020 - Wiley Online Library
Abstract
Psilocybin is being developed for treating major depressive disorder. Psilocybin is readily dephosphorylated to psilocin upon absorption. The potential for psilocin proarrhythmic effect was assessed using a concentration‐QTc interval (C‐QTc) analysis from an open‐label …
Last updated: Jul 27, 2020